Bird Flu Kills over 900 Seals, Sea Lions in South Brazil

File photo: Sea lions are seen on a street of Mar del Plata harbor during the lockdown due to the coronavirus pandemic, in Mar del Plata, some 400 km south of Buenos Aires, Argentina | AFP.
File photo: Sea lions are seen on a street of Mar del Plata harbor during the lockdown due to the coronavirus pandemic, in Mar del Plata, some 400 km south of Buenos Aires, Argentina | AFP.
TT

Bird Flu Kills over 900 Seals, Sea Lions in South Brazil

File photo: Sea lions are seen on a street of Mar del Plata harbor during the lockdown due to the coronavirus pandemic, in Mar del Plata, some 400 km south of Buenos Aires, Argentina | AFP.
File photo: Sea lions are seen on a street of Mar del Plata harbor during the lockdown due to the coronavirus pandemic, in Mar del Plata, some 400 km south of Buenos Aires, Argentina | AFP.

Nearly 1,000 seals and sea lions in southern Brazil have died from bird flu outbreaks, say authorities, who are scrambling to isolate the deadly virus from commercial poultry flocks.
The southernmost state of Rio Grande do Sul has confirmed an unprecedented 942 sea mammal deaths following infection by the highly pathogenic avian influenza (HPAI), which was reported for the first time ever in the South American country this year.
Oceanographer Silvina Botta, at the Rio Grande Federal University (FURG), said the carcasses have to be buried or incinerated as soon as possible to reduce the risk of contaminating humans or other animals.
Scientists have also found some sea mammals convulsing along local beaches, as the virus attacks their nervous system. Under government health regulations, animals have to be euthanized to spare "a very painful death," Botta said.
Since Brazil's first report of HPAI in wild birds in May, the Agriculture Ministry says preventive measures have avoided an outbreak on commercial poultry farms, which could trigger export bans against Brazil, the world's top chicken exporter.
But the virus has run rampant in other animal populations. In addition to the outbreaks among seabirds, seals and sea lions, authorities have collected samples of dead porpoises and penguins found on beaches, with no confirmed results yet.
Botta said the first diagnosis of HPAI-related sea mammal deaths in Rio Grande do Sul came in September, when unusual mortality rates caught scientists' attention. Three towns in the state still have active outbreaks.
She said the contagion among sea mammals appears to have started in Peru and then circled the South American continent, hitting wildlife in Chile, Argentina, Uruguay and now Brazil.
Brazil's Agriculture Ministry reported 148 HPAI outbreaks in the country, mostly along the coast, declaring a health emergency to contain the disease, which it says "is not yet considered endemic in Brazil."
Avian influenza, commonly known as bird flu, has led to the culling of hundreds of millions of farm animals in Europe and the United States.



Ozempic Hailed as 'Fountain of Youth' that Slows Aging

The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
TT

Ozempic Hailed as 'Fountain of Youth' that Slows Aging

The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
The is available under the brand names Wegovy and Ozempic (Photo by Reuters)

The anti-obesity drug Ozempic could slow down ageing and has “far-reaching benefits” beyond what was imagined, researchers have suggested.

Multiple studies have found semaglutide (available under the brand names Wegovy and Ozempic) reduced the risk of death in people who were obese or overweight and had cardiovascular disease without diabetes, The Independent reported.

Responding to research published in JACC, the flagship journal of the American College of Cardiology, Professor Harlan M Krumholz from the Yale School of Medicine, said: “Semaglutide, perhaps by improving cardiometabolic health, has far-reaching benefits beyond what we initially imagined.”

He added: “These ground-breaking medications are poised to revolutionise cardiovascular care and could dramatically enhance cardiovascular health.”

Multiple reports also quoted Professor Krumholz saying: “Is it a fountain of youth?”

He said: “I would say if you’re improving someone’s cardiometabolic health substantially, then you are putting them in a position to live longer and better.

“It’s not just avoiding heart attacks. These are health promoters. It wouldn’t surprise me that improving people’s health this way actually slows down the ageing process.”

The studies, presented at the European Society of Cardiology Conference 2024 in London, were produced from the Select trial which studied 17,604 people aged 45 or older who were overweight or obese and had established cardiovascular disease but not diabetes.

They received 2.4 mg of semaglutide or a placebo and were tracked for more than three years.

A total of 833 participants died during the study with 5 percent of the deaths were related to cardiovascular causes and 42 per cent from others.

Infection was the most common cause death beyond cardiovascular, but it occurred at a lower rate in the semaglutide group than the placebo group.

People using the weight-loss drug were just as likely to catch Covid-19, but they were less likely to die from it – 2.6 percent dying among those on semaglutide versus 3.1 per cent on the placebo.

Researchers found women experienced fewer major adverse cardiovascular events, but semaglutide “consistently reduced the risk” of adverse cardiovascular outcomes regardless of sex.

Dr Benjamin Scirica, lead author of one of the studies and a professor of cardiovascular medicine at Harvard Medical School, said: “The robust reduction in non-cardiovascular death, and particularly infections deaths, was surprising and perhaps only detectable because of the Covid-19-related surge in non-cardiovascular deaths.

“These findings reinforce that overweight and obesity increases the risk of death due to many etiologies, which can be modified with potent incretin-based therapies like semaglutide.”

Dr Jeremy Samuel Faust, an emergency medicine physician at Brigham and Women’s Hospital, praised the researchers for adapting the study to look at Covid-19 when the pandemic started.

He said the findings that the weight-loss drug to reduce Covid-19 mortality rates were “akin to a vaccine against the indirect effects of a pathogen.”